Delivery Order SPE2DB24D1021-SPE2DB24FEUJB
Award Date
9/25/24
Potential Completion Date
9/26/24
Potential Value
$85K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML. The contract is a Delivery Order with a Firm Fixed Price of $3,946.32 and has an ultimate completion date of August 14, 2024. This award is not associated with any set-aside program. As a prominent supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This federal contract award was made by the Defense Logistics Agency (DLA), a major defense agency, to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The $7,271.33 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication, to support military treatment facilities and other government healthcare programs. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen, through its extensive federal...
This federal contract award is for the delivery of Actemra Actpen 162 mg/0.9 ml 0.9 ml medication, valued at $21,418.69. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a period of performance through February 22, 2024 and is a firm fixed-price Delivery Order. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,384.37 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty injectable medication. The award has an ultimate completion date of October 11, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $7,465.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D3401|SPE2DB25FT3PE) for the medication Actemra Actpen 162 mg/0.9 ml, with a performance period ending on May 12, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML medical supplies, with a firm fixed price ceiling value of $43,221.23 and a completion date of December 17, 2024. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds...
This federal contract award, valued at $51,988.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of the medication ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML. The contract is a firm fixed-price, non-set-aside award with a performance period through May 8, 2025. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, to supply Actemra Actpen 162 mg/0.9 ml drug vials. The $15,530.73 Firm Fixed Price delivery order contract has an ultimate completion date of August 29, 2024. Amerisourcebergen, through its Corporate Office division, provides a wide range of pharmaceutical and medical supplies to various government agencies and healthcare programs, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,585.73 firm fixed-price delivery order is for the medical product ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML. The contract has an ultimate completion date of November 15, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,397.75 Firm Fixed Price Delivery Order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of November 5, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...